PROGRESSIVE B-CLL WITH HEPATIC-FAILURE - RESPONSE TO FLUDARABINE (FLU) AND BILIRUBIN PHARESIS

被引：0
|
作者：
PICKENS, P
SARIS, A
OBRIEN, C
机构：
[1] ABINGTON MEM HOSP,ABINGTON,PA 19001
[2] HOSP UNIV PENN,PHILADELPHIA,PA 19104
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A575 / A575
页数：1
相关论文
共 50 条
  • [1] Evans syndrome complicating fludarabine treatment for advanced B-CLL
    Shvidel, L
    Shtarlid, M
    Klepfish, A
    Sigler, E
    Berrebi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) : 706 - 706
  • [2] Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes
    Adams, DJ
    Levesque, MC
    Weinberg, JB
    Smith, KL
    Flowers, JL
    Moore, J
    Colvin, OM
    Silber, R
    LEUKEMIA, 2001, 15 (12) : 1852 - 1859
  • [3] IN-VITRO SENSITIVITY OF B-CLL CELLS TO FLUDARABINE AND INTERFERONS
    DIRAIMONDO, F
    GUGLIELMO, P
    PALUMBO, GA
    CACCIOLA, E
    GIUSTOLISI, R
    CACCIOLA, E
    BLOOD, 1993, 82 (10) : A563 - A563
  • [4] IN-VITRO SENSITIVITY OF B-CLL CELLS TO FLUDARABINE AND INTERFERONS
    DIRAIMONDO, F
    PALUMBO, GA
    ROMEO, MA
    CACCIOLA, E
    MILONE, G
    IMPERA, S
    GIUSTOLISI, R
    CACCIOLA, E
    LEUKEMIA & LYMPHOMA, 1995, 17 (5-6) : 449 - 453
  • [5] Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes
    DJ Adams
    MC Levesque
    JB Weinberg
    KL Smith
    JL Flowers
    J Moore
    OM Colvin
    R Silber
    Leukemia, 2001, 15 : 1852 - 1859
  • [6] Fludarabine (FLU)-containing regimen and rituximab (RI) as primary therapy with curative intent for younger patients with progressive and advanced B-CLL: High rate of initial response including molecular remissions.
    Polliack, A
    Cohen, Y
    Daas, N
    Libster, D
    Shvidel, L
    Klepfish, A
    Shtalrid, M
    Haran, M
    Berrebi, A
    BLOOD, 2001, 98 (11) : 364A - 364A
  • [7] Genetic aberrations and response to fludarabine as first line treatment in a serie of B-CLL patients.
    Giraldo, P
    Rubio-Martinez, A
    Recasens, V
    Valganon, M
    Latre, P
    Rubio-Felix, D
    Calasanz, MJ
    Odero, MD
    BLOOD, 2005, 106 (11) : 603A - 603A
  • [8] BILIRUBIN REMOVAL FROM AN HEPATIC-FAILURE PATIENT BY RESIN HEMOPERFUSION
    MOR, L
    SIDEMAN, S
    MIHICH, M
    TAITELMAN, U
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1981, 4 (03): : 146 - 147
  • [9] May fludarabine (FAMP) favour occurrence of Righter's syndromeduring B-CLL?
    Desablens, B
    Garidi, R
    Tabuteau, S
    Fernandes, J
    Capiod, JC
    Legrand, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 192 - 192
  • [10] Increased serum levels of soluble Fas in progressive B-CLL
    Osorio, LM
    Aguilar-Santelises, M
    De Santiago, A
    Hachiya, T
    Mellstedt, H
    Jondal, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (05) : 342 - 346
12345